Oral Abstracts: Primary HIV Infection, Early Treatment, and Immune-Based Therapies for Chronic Infection
Moderator
Robert Grant
J David Gladstone Inst, San Francisco, CA, US
Moderator
Cara Wilson
Univ of Colorado Hlth Sci Ctr, Denver, US
"HIV in Genital Fluids during Heterosexual Transmission"
Debrah Boeras
Emory Univ, Atlanta, GA, US
"Complex HIV-1 Populations Prior to Seroconversion in Men Who Have Sex with Men: Analysis of HIV-1 Plasma RNA Positive-Seronegative Subjects from the MACS"
Geoffrey Gottlieb
Univ of Washington, Seattle, US
"HIV-1 Envelopes from Acute and Chronic Infection Differ in Their Levels of Fusogenicity and Sensitivity to Inhibition with sCD4"
Terri Wrin
Monogram Biosci, South San Francisco, CA, US
"Immunodomination by HLA-B27- and HLA-B57-restricted HIV-1-specific T-cell Responses Results in Abrogation of other HLA-restricted Responses in Primary HIV-1 Infection"
Hendrik Streeck
Partners AIDS Res Ctr, Massachusetts Gen Hosp, Harvard Med Sch, Boston, US
"Early Treatment of Primary HIV-1 Infection Lowers the Viral Set Point"
Radjin Steingrover
Academic Med Ctr, Univ of Amsterdam, The Netherlands
"No Benefit from Early Treatment in Primary HIV-infection?"
Christine Koegl
IMUC Res, Munich, Germany
"Time to ART Resumption following Treatment Interruption Is Shorter for Individuals Immunized with HIV-Recombinant Canarypox Vaccine (Vcp1452) Compared to Placebo: The Manon-02 Trial"
Brigitte Autran
Hosp Pitie-Salpetriere, Paris, France; Univ Pierre et Marie Curie, Paris, France; INSERM U543, Paris, France;
"Repeated r-hIL-7 Doses Improve T-cell Recovery in HIV-1-infected Patients Enrolled in a Phase I/II Multicentric Study"
Y. Levy
INSERM, Creteil, France and Henri Mondor Hosp, Creteil, France
"rhIL7 in HIV-1-infected Subjects with CD4 T-cell Count >100cells/µL and Viral Load <50,000 copies/mL: Results from a Randomized, Placebo-controlled, Double-blinded Study (ACTG5214)"
Irini Sereti
NIAID, NIH, Bethesda, MD, US
"In Chronic HIV-1 infection, Cyclosporine A Provides No Sustained Immunologic Benefit to Persons Starting ART"
Michael Lederman
Case Western Reserve Univ, Cleveland, OH, US
|
|
